Long-term survival after significant treatment reduction in a patient with CBF-AML

Pediatr Blood Cancer. 2011 Feb;56(2):325-6. doi: 10.1002/pbc.22854. Epub 2010 Nov 11.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Core Binding Factor beta Subunit / genetics
  • Core Binding Factors / genetics*
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / genetics
  • Leukemia, Myeloid, Acute / mortality*
  • Male
  • Myosin Heavy Chains / genetics

Substances

  • Antineoplastic Agents
  • Core Binding Factor beta Subunit
  • Core Binding Factors
  • MYH11 protein, human
  • Myosin Heavy Chains